Nurix Therapeutics, Inc. — TTAB Proceedings

Nurix Therapeutics, Inc. is a party to 3 TTAB proceedings.

Proceedings

Proceeding 99457078 — Extensions of Time to Oppose, Not Instituted (filed 2026-05-07) against Bayer Aktiengesellschaft as defendant
Proceeding 97693532 — Extensions of Time to Oppose, Terminated (filed 2026-03-26) against Médical Nura Inc. as plaintiff
Proceeding 92075489 — Cancellations, Terminated (filed 2020-10-12) against AstraZeneca AB as plaintiff

2026-05-07: 99457078 — EXTENSION OF TIME GRANTED involving Bayer Aktiengesellschaft
2026-05-07: 99457078 — FIRST 30-DAY REQUEST TO EXT TIME TO OPPOSE involving Bayer Aktiengesellschaft
2026-04-29: 97693532 — TERMINATED involving Médical Nura Inc.
2026-04-28: 97693532 — RELINQUISHMENT ACKNOWLEDGED; APPLICATION RELEASED TO TRADEMARKS involving Médical Nura Inc.
2026-04-28: 97693532 — P RELINQUISHMENT OF EXT involving Médical Nura Inc.
2026-03-26: 97693532 — EXTENSION OF TIME GRANTED involving Médical Nura Inc.
2026-03-26: 97693532 — FIRST 90-DAY REQUEST TO EXT TIME TO OPPOSE involving Médical Nura Inc.
2021-02-01: 92075489 — TERMINATED involving AstraZeneca AB
2021-02-01: 92075489 — COMMR ORDER CANCELLING REG involving AstraZeneca AB
2021-01-29: 92075489 — BOARD'S DECISION: GRANTED involving AstraZeneca AB
2020-12-05: 92075489 — NOTICE OF DEFAULT involving AstraZeneca AB
2020-10-16: 92075489 — PENDING, INSTITUTED involving AstraZeneca AB
2020-10-16: 92075489 — NOTICE AND TRIAL DATES SENT; ANSWER DUE: involving AstraZeneca AB
2020-10-12: 92075489 — FILED AND FEE involving AstraZeneca AB